Nonetheless, when recurrent tumor cells were isolated and transplanted into naive animals, they observed that gliomas regained sensitivity to CSF-1R inhibition, suggesting that resistance to CSF-1R inhibition is driven by the TME. Here, CSF1R is linked to central nervous system cancer.